中文

  • Increase the probability
    of your products' success

  • COVID-19
    dMed actively supports clients trials

Our Vision

The Leading Next Generation global clinical...

Read More

Our Culture

Innovation, Collaboration and Passion...

Read More

Our Team

Trust and Professionalism are well recognized traits...

Read More

Words from the Founder

The global pharmaceutical industry is in the era of innovation filled with exciting opportunities. dMed, a Next Generation CRO, is well positioned to take advantage of these shifts in the global pharma industry by being the bridge between two of the world's largest pharmaceutical markets, the US and China. dMed operates at the highest international clinical standards and brings together the strengths and opportunities inherent in these markets.

Dr. Lingshi Tan, Chairman & CEO

Regulatory Affairs and Strategy

Early Development & Clinical Pharmacology

Clinical Science and Medical Affairs

Quality Assurance

Consultation

e*CRO -- Clinical Trial Software

China:
298 Xiangke Road, 3/F, 301-305, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201210, China
Tel: +86 21 5090 0085 Fax: +86 21 6875 5515
US:
261 Madison Avenue, 24th fl. New York, NY 10016 US
Phone: +1-212-681-2100
沪ICP备16041651号 Copyright © 2016 dMed All Rights Reserved
沪公网安备 31011502005403号